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Abstract
Background: There is a traditional tension in public policy between the maximization of welfare from given
resources (efficiency) and considerations related to the distribution of welfare among the population and to
social justice (equity). The aim of this paper is to measure the relative weights of the efficiency- and equity-
enhancing criteria in the preferences of health policy-makers in Israel, and to compare the Israeli results with
those of other countries.
Methods: We used the criteria of efficiency and equity which were adopted in a previous international study, adapted
to Israel. The equity criteria, as defined in the international study, are: severity of the disease, age (young vs. elderly),
and the extent to which the poor are subsidized. Efficiency is represented by the criteria: the potential number of
beneficiaries, the extent of the health benefits to the patient, and the results of economic assessments (cost per
QALY gained). We contacted 147 policy-makers, 65 of whom completed the survey (a response rate of 44%). Using
Discrete Choice Experiment (DCE) methodology by 1000Minds software, we estimated the relative weights of these
seven criteria, and predicted the desirability of technologies characterized by profiles of the criteria.
Results: The overall weight attached to the four efficiency criteria was 46% and that of the three equity criteria was
54%. The most important criteria were “financing of the technology is required so that the poor will be able to receive
it” and the level of individual benefit. “The technology is intended to be used by the elderly” criterion appeared as the
least important, taking the seventh place. Policy-makers who had experience as members of the Basket Committee
appear to prefer efficiency criteria more than those who had never participated in the Basket Committee deliberations.
While the efficiency consideration gained preference in most countries studied, Israel is unique in its balance between
the weights attached to equity and efficiency considerations by health policy-makers.
Discussion: The study explored the trade-off between efficiency and equity considerations in the preferences of health
policy-makers in Israel. The way these declarative preferences have been expressed in actual policy decisions remains
to be explored.
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Background
There is a traditional and long-standing tension in eco-
nomics between efficiency - defined as the maximization
of welfare - and equity, which includes considerations of
equality, the distribution of welfare and social justice.
In terms of health policy, the aspiration to efficiency is
equivalent to the maximization of health. When health
is measured as Quality Adjusted Life Years (QALYs), as
is the case in economic assessments of health technolo-
gies, efficiency is identified with the maximization of
QALYs. However, maximization of health itself does not
take into account considerations of equality, justice,
medical need, etc. [1], and when health policy is con-
cerned with the sick or poor, some efficiency might have
to be given up.
Policy-makers try to “conciliate” [2] between efficiency
and equity considerations when formulating health policy.
However, the trade-offs between efficiency and equity are
seldom made explicit, and they are usually dealt with on
an “ad hoc” basis. Alan Williams, the eminent British
health economist, stated: ‘Health systems typically pursue
two broad objectives: to maximize the health of the popu-
lation served, and to reduce inequalities in health…there
is conflict between achievement of these two objectives, so
that – in setting policy – an explicit weight should be
given to each’ ([3], p. 64).
The purpose of this study is to estimate these weights
in the preferences of Israeli health policy-makers and
compare them to the results in other countries.
Making health policy under multi-criteria conditions
Decisions on the allocation of social resources among
competing uses in health systems are extremely com-
plex. The amount of resources available to the health
system is limited, and cannot possibly satisfy all the
wants and needs of the population. The decision area
which most sharply and dramatically represents the need
for priority setting is that of determining which new
technologies will receive public funding (within the
package of benefits) and which will not. In this situation,
priority setting becomes vital and common in many sys-
tems. However, this only serves to emphasize the issue
of the necessity to consider several and sometimes-
contradictory criteria – in many cases equity and effi-
ciency – in decision- making and formulation of health
policy. Economic assessments, e.g. cost effectiveness ana-
lysis, a primary tool used for prioritizing new technologies
in terms of efficiency, do not take into account the distri-
bution of health gains and healthcare among citizens.
Most of the countries where the package of benefits is
funded by public money struggle with the question of
how to maintain a formal prioritization process that is
not only transparent and evidence-based but also reflects
public preferences, at least those of policy-makers. This
process should be guided by a presentation of criteria to-
gether with their weights, in order to yield efficient, fair
and consistent decisions, reflecting public preferences.
An international study (hereinafter “the international
study”) has recently begun to explore the importance of
different criteria in the decision-making processes in dif-
ferent countries. Results have been collected in these
countries: Uganda, Nepal, Brazil, Cuba and Norway [4, 5],
as well as Austria [6], Spain [7], China [8] and Hungary
[9]. All the countries made use of the DCE methodology,
with a similar questionnaire (adapted to each national
health system) and with analysis, which follows standard-
ized protocol that allows cross-country comparisons. Six
criteria reflected the mix of efficiency and equity consider-
ations in the comparison of various technologies: disease
severity, number of potential beneficiaries, age groups of
potential beneficiaries, the level of the health benefits
enjoyed by the beneficiaries of the technology, the ex-
tent of willingness to subsidize the poor, and the cost-
effectiveness of the technologies.
Israel faces similar concerns. Two recent Israeli studies
report relevant findings. A 2008 study concluded, on the
basis of an extensive review of the literature, that three
main considerations stand at the basis of the prioritization
of new technologies: (1) medical need, appropriateness
and clinical benefit (2) efficiency (3) equality, solidarity
and other ethical or social values [10].
Another study of 2011 [11] found that the preferences
of the policy-makers in Israel were related to the benefit,
reduction of inequality, lifesaving and allocation to
special populations. A greater importance had been
attached to the reduction of inequalities than to life
extending (for a short term), and the consideration of
benefit was preferred in comparison with life-extending
and inequality reduction.
Objectives
The objective of this study is to analyze the relative im-
portance of efficiency and equity considerations in the
preferences of the health policy-makers in Israel at the
declarative level, and to compare the Israeli results with
the results obtained in the international study.
Methods
The questionnaire
The data collection process for Israel followed the same
protocol as that of the international study with a Hebrew
version of the questionnaire. The questionnaire was
adapted to the characteristics of the Israeli system.
Based on literature reviews and focus groups, the
international study identified six key criteria used in
health policy decisions. Each criterion is measured
using “levels” (see below for more details). The criteria
and their levels were:
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1. Disease severity – measured by healthy life expectancy
(2 levels – more than 2 years or less)
2. Total beneficiaries – number of affected patients
who could potentially benefit (2 levels – more
than 100,000 or less)
3. Age – target age groups (3 levels - young, middle,
and old ages)
4. Individual benefits (2 levels – more than 5 years in
full health or less),
5. Willingness to subsidize the poor (2 levels – greater
than 70% government subsidization or less),
6. Cost-effectiveness (2 levels - cost per QALY
gained more than Gross National Product per
capita or less).
Albeit “willingness to subsidize the poor” is used in
other countries, this criterion is not relevant in Israel,
where a National Health Insurance system operates and
funds all technologies included in the national package
of health benefits (apart from a small copayment).
Hence, this criterion was defined as: “The funding of the
technology is necessary so that the poor will also be able
to receive it” – yes or no. This definition was accompanied
by the clarification that it is intended to reflect situations
where the cost of the technology to the individual is rela-
tively low such that most of the population would be able
to purchase it either out of pocket or via complementary
or private insurance policies, but the poor would not be
able to use it without public funding. For example, the ac-
tual copayment in infant vaccination or pregnancy screen-
ing tests in Israel is relatively high and many poor families
refrain from using these services.
The age criterion was adjusted to provide clarity to
the respondents and was split into two separate criteria
representing mutually exclusive age groups: “The tech-
nology is intended to treat a disease common primarily
among children” – yes or no, and “the technology is
intended to treat a disease common primarily among
the elderly” – yes or no. These two criteria do not ap-
pear as “yes” for both for the same technology, but
could appear as “no” for both, meaning that the tech-
nology is intended to treat a disease common primarily
among middle- aged patients, or a disease which is not
age related.
Criteria classification
Following the international study, equity criteria were
defined as those dealing with the distributional impact
across subpopulations, and included: disease severity,
age (including all the age groups), and willingness to
subsidize the poor (as adapted to Israel). Efficiency cri-
teria included: the potential number of beneficiaries, the
health benefit to the individual patient and the results of
the economic assessment (cost per QALY).
We note that the preference of a technology intended
primarily for children over one intended primarily for
the elderly might express (also) an efficiency consider-
ation, since the treatment of a child yields more life
years (in better health) than treatment given to an
elderly person. Below we used the two classifications of
the age criteria.
Estimation
DCE, also called Conjoint Analysis, is a declarative
method which makes use of a questionnaire which de-
tails various combinations of the attributes’ (criteria)
levels to measure the preferences and the relative im-
portance assigned to each criterion [12].
The method is based on repetitive selections between
pairs of technologies by various combinations of the
criteria levels. A series of pairs is presented to the re-
spondent, where each one includes two different sce-
narios (combinations of the various levels of each of
the criteria) and the respondent selects which of the
scenarios (“technologies”) she prefers.
The analysis in the international study used the condi-
tional logit model. The importance of the criterion is
reflected by its estimated coefficient in a regression
where the dependent variable is the probability of selec-
tion one technology over the other. For any profile of
the criteria (i.e., a set of criteria levels), the predicted
probability of selection can be calculated. In this study, the
conjoint analysis was conducted using the internet-based
software “1000Minds”, a software used for prioritization
and ranking. The software uses a unique method for
deriving weights, known as PAPRIKA (‘Potentially All
Pairwise RanKings of all possible Alternatives’) [13].
For any profile of the criteria, a predicted desirability
(scored 0–100 or 0–1) can be calculated.
Because of the transitivity property used by the soft-
ware, the number of questions that every participant
has to answer varies based on the participant’s re-
sponses. In this survey, which includes 7 criteria (recall
that the age criterion had been decomposed into two
criteria), each of which is defined with 2 levels, an aver-
age of 12 questions were required in order to calculate
the weights of the criteria.
A small pilot involving five policy-makers was con-
ducted and the questionnaire was revised based on their
comments.
The Sample
The sample was compiled from the distribution list of
the National Institute for Health Policy Research and the
invitation list to the last Dead Sea Conference (December
2013), which gathers Israeli health policy-makers to dis-
cuss issues related to Israeli health policy. It included
past and present senior managers from the Ministry of
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Health, Ministry of Finance, sickness funds, Israeli
Medical Association, and hospital directors.
Data collection process
The questionnaire was administered online inviting par-
ticipants through email. An explanation sheet introduced
the survey along with detailed definitions of each of the
criteria, as described above. Following the survey, partici-
pants were requested to provide some demographic infor-
mation. In total, out of the 147 policy-makers contacted,
65 completed the choice experiment (a response rate of
44%). Because of technical difficulties related to the possi-
bility of opening Google documents discovered later, only
40 provided full demographic details.
Of those participants who completed the survey: 22
were from the sickness funds, 8 from the Health Minis-
try, either currently or in the past, 15 were hospital di-
rectors (2 of whom had previously served in key Health
Ministry positions), 4 were past chairmen of the Public
Committee for the Determination of the Package of
Benefits (the “Basket Committee”), 1 from the Finance
Ministry, 2 from the Israel Medical Association and 2
from the management of the National Institute for
Health Policy Research.
International comparisons
The preferences of the Israeli health policy-makers were
compared with those of the policymakers in the coun-
tries of the international study. Given the different DCE
method implemented in the present study, the compari-
son consisted of the following components: First, the
relative ranking of the criteria was compared. Second,
the predicted Israeli ranking was obtained for a sample
of hypothetical technologies (taken from [4]). Three
hypothetical technologies were defined: S0 – a technology
where all the criteria are at a high level (“yes”), S1 – a
technology where all the equity criteria are at a high level
and the efficiency criteria at a low level, and S2 – a tech-
nology where all the efficiency criteria are at a high level
and the equity criteria at a low level. This comparison was
performed by calculating the relative desirability of tech-
nologies S2 and S1 with respect to technology S0. These
were compared with the predicted probabilities of selec-
tion in the international study.
We also calculated the ranking of an additional tech-
nology (S1.1) which is intended primarily for children, as
well as of a technology (S1.2) which is intended both for
children and for the elderly.
Third, the predicted Israeli ranking of a sample of ac-
tual health technologies was obtained and compared to
that obtained in Austria and Spain. The characteristics
of the technologies were taken from the Austrian study.
Results
The importance of the efficiency and equity
considerations in Israel
Table 1 presents the mean weights of the different criteria,
as derived from the survey. The most important criteria
are “funding the technology is necessary so that the poor
will also be able to receive it”, clearly an equity criterion,
and “benefit to the individual”, a significant efficiency cri-
teria. The third ranked criterion is also an efficiency criter-
ion “the number of patients requiring the technology”.
The fourth is an equity criterion (as per the international
study) or an efficiency criterion (by the alternative defin-
ition) which specifies whether the technology was
intended mainly for children. The criterion regarding
whether the technology was intended primarily for the
elderly is, however, the least important, taking the seventh
place. The fifth criterion is “cost per QALY” which is the
most significant efficiency criterion, and the sixth is the
criterion “the technology is intended for patients suffering
from a serious disease”, an equity criterion.
In total, according to the international study’s classifi-
cation, the efficiency criteria comprise a total weight of
46% and the equity criteria – 54%. According to the al-
ternative definition (preference of technologies intended
for children seen as an efficiency criteria), the equity cri-
teria weight drops to 40% and the efficiency criteria
weight rises to 60%.
































Type of criteria equity equity equity equity efficiency efficiency efficiency
Total respondents 65 11% 19% 14% 10% 19% 15% 12% 100%
Rank 6 1 4 7 1 3 5
International study
definitions
Equity weight = 54% Efficiency weight = 46% 100%
Alternative
definitiona
Equity weight = 40% Efficiency weight = 60% 100%
aSeeing the criteria “the technology is targeted to children” as an efficiency criterion
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The importance of efficiency and equity considerations in
selected groups of the Israeli health policy-makers
The 40 respondents who responded to the demographic
survey (and could be assigned to specific subgroups)
assigned somewhat different weights, compared to those
who did not, to the two age-criteria: They assigned sig-
nificantly higher weight to the criterion specifying that
the technology is mainly used by children (16% vs. 11%),
and lower weight to the criterion specifying that the
technology is used mainly by the elderly (9% vs. 12%)
(Table 2). The overall weights assigned to the equity and
efficiency criteria are similar (Table 3), however.
Table 2 also presents the relative importance of the
criteria among respondents aged 65+ and younger, phy-
sicians and non-physicians, and policy-makers who have
ever been members of the public Basket Committee
compared to respondents who have never served on that
committee. In general, the results indicate that the
weights of the criteria are not affected by these character-
istics. Two exceptions stand out: First, physicians assign
lower weight than non-physicians to the criterion of the
number of potential patients – an efficiency consideration
(14% vs. 18%). Second, respondents who have experienced
the difficulty involved in multi-criteria decision-making
and prioritization of technologies during their service as
members of the Basket Committee assigned significantly
higher importance to the criterion of cost per QALY
gained, the main efficiency criterion (16% vs. 11%), and
significantly lower importance to the equity criterion
regarding the accessibility of the technology to the poor
(21% vs. 16%).
Table 3 presents the overall weights of the equity and
efficiency considerations in the preferences of various
subgroups of policy-makers, according to two classifi-
cations of equity and efficiency. While there is no
difference in the weight of equity and efficiency
considerations between the age groups and between
physicians and non-physicians, significant differences
exist between those who have served on the Basket
Committee and those who have not. Respondents who
have participated in the Basket Committee assigned
higher weights to efficiency considerations (52% ac-
cording to the international study’s definition and 66%
according to the alternative definition) than other re-
spondents (44% and 60% respectively).
International comparisons of health policy-makers’
preferences
The Israeli sample (65 respondents) was relatively large,
as were the samples in studies conducted in Nepal (66),
































Type of criterion equity efficiency equity equity efficiency equity efficiency
Age above 65 11 9% 16% 16% 10% 17% 19% 12% 100%
Age under 65 29 10% 16% 16% 8% 19% 20% 12% 100%
P* 0.62 0.82 0.75 0.27 0.34 0.68 0.95
Physician 25 11% 14% 16% 9% 18% 20% 12% 100%
Non-physician 15 8% 18% 15% 9% 18% 19% 13% 100%
P* 0.19 0.04 0.65 0.95 0.98 0.75 0.61
Served on Basket
Committee
11 9% 16% 15% 9% 20% 16% 16% 100%
Never did 29 10% 16% 16% 9% 17% 21% 11% 100%










25 13% 13% 11% 12% 21% 17% 12% 100%
P* 0.17 0.25 0.00 0.02 0.28 0.37 0.88
Total 65 11% 15% 14% 10% 19% 19% 12% 100%
*2-tailed t-test of equality. Significant differences are in boldface
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Spain (69), Austria (70), China (78) and Brazil (73). In
the other countries the samples were smaller: 32–34 par-
ticipants in Norway, 37 in Cuba, 52 in Hungary, and 17
in Uganda. Unlike the studies conducted in Austria,
Spain and Norway, where the participants also included
academics, in the Israeli study, all the participants were
health policy-makers. From an experience standpoint,
the vast majority of the participants in this study (90% of
the participants in the demographic study) had 10 or
more years of experience. This is comparable to the
samples of studies in Spain, Norway [5], and Uganda,
where only professionals with 10 or more years of ex-
perience participated in the study.
Comparison of the criteria ranking
As the methodology used in the Israeli study differs
from that used in the other countries, a direct com-
parison of the weights assigned to the different cri-
teria was not possible. Instead, we ranked the criteria
by their weight (Israel) or effect (elsewhere). The
criteria rankings are presented in Table 4 (based on
[4–7, 12, 13]).
In most of the countries, the efficiency considerations
out-rank the equity considerations. In Israel the findings
point to a balance between the equity and efficiency
considerations which are alternately ranked. For ex-
ample, the cost per QALY criterion, a prominent
Table 3 The overall weights of the efficiency and equity criteria in selected groups of Israeli health policy-makers
Number of
respondents
International study definitions Alternative definitionsa
Equity weight Efficiency weight Total Equity weight Efficiency weight Total
Age above 65 11 55% 45% 100% 38% 62% 100%
Age below 65 29 54% 46% 100% 38% 62% 100%
P* 0.73 0.73 0.89 0.89
Physician 25 56% 44% 100% 40% 60% 100%
Not physician 15 51% 49% 100% 36% 64% 100%
P* 0.21 0.21 0.26 0.26
Served on the Basket Committee 11 49% 51% 100% 34% 66% 100%
Never did 29 56% 44% 100% 40% 60% 100%
P* 0.03 0.03 0.04 0.04
Respondents who answered the
demographic questionnaire
40 54% 46% 100% 38% 62% 100%
Respondents who did not answered
the demographic questionnaire
25 53% 47% 100% 42% 58% 100%
P* 0.98 0.98 0.07 0.07
Total 65 54% 46% 100% 40% 60% 100%
*2-tailed t-test of equality. Significant differences are in boldface
aSeeing the criteria “the technology is targeted to children” as an efficiency criterion
Table 4 Criteria ranking – comparison between countriesa
Criteria Israel Brazil Cuba Uganda Nepal Norway Austria Spain Hungary China
Disease severity 6 4 6 2 3 4 5 5 4 5
Number of patients 3 2 1 4 5 6 4 4 7 3
Individual benefit 1 3 5 6 2 3 1 2 1 4
Subsidy to the poor 1 6 3 5 7 7 7 6 5 7
Cost effectiveness 5 1 7 3 4 2 3 1 3 1
Intended for middle-age vs. childrenb 4 5 2 7 6 5 6 7 6 2
Intended for the elderly vs. childrenc 7 7 4 1 1 1 2 3 2 6
Rank correlation with Israeld 1 0.20 0.36 −0.79 −0.52 −0.65 −0.18 −0.14 −0.18 −0.05
P* 0.66 0.42 0.04 0.22 0.10 0.70 0.76 0.70 0.91
*T-test of the hypothesis that the rank correlation = 0. Significant correlations are in boldface
aWhenever interactions appeared in the model, the ranking was based on the mean effect
bIsrael: children vs. other
cIsrael: elderly vs. other
dAdjusted for ties
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efficiency one, was ranked fifth in Israel, but was
ranked in one of the three first places in Brazil,
Uganda, Norway, Austria, Spain, Hungary and China.
On the other hand, the subsidizing the poor criteria, a
significant equity one, was ranked first in Israel, but as
last in Nepal, Austria, Norway and China, and as sixth
in Brazil and Spain.
Overall, the Israeli ranking is not in accordance (rank
correlations are not different from zero) with the rank-
ings in all countries but Uganda and Norway where
negative correlations were found.
Comparison of the ranking of hypothetical technologies
The Israeli prioritization of the hypothetical technologies
S0, S1, S1.1, S2 and S1.2 is presented in Table 5. The
comparison between Israel and other countries is given
in Table 6.
The main finding of this comparison is again the bal-
ance between the equity and efficiency considerations in
Israel: The gap between the desirability score assigned to
technology S1, which is entirely pro-equity, and the
score of technology S2, which is entirely pro-efficiency,
is only 6 percentage-points in favour of efficiency.
In all the other countries [4], the gaps are significantly
larger. In all the countries with the exception of Cuba the
above gaps are in favour of the efficiency considerations
(technology S2).
In Norway and Nepal the preference for technology
S2 is greater than that for the base technology (S0). In
Cuba, however, the preference for technology S1 is high
compared to the base technology (S0).
Comparison of the rankings of selected actual
technologies
The results of this comparison are presented in Table 7.
Examination of the table reveals a relatively high correlation
among the rankings found in Israel, Austria and Spain.
The technologies that were ranked in first place in the
Israeli survey appear at the head of the table. Those
technologies were ranked in fourth place in Austria and
Spain, after the three psychiatric technologies which were
ranked in first place. These, in turn, were ranked only in
the 26th place in Israel. However, examination of the data
reveals that the psychiatric technologies were the only
ones originally classified as “no” in the criterion of willing-
ness to subsidize the poor. As a result, these technologies
“lost” 19% (the weight assigned to this criterion by the
Israeli survey participants), so the overall weight assigned
to them was 57%. Notwithstanding this result – which is
based, it would seem, on the lack of an adequate allocation
for the treatment of psychiatric disorders in high-income
countries (“At present the prospects of an increasing bur-
den of disease for mental disorders are not matched by
adequate mental health care spending in high-income
countries …” [6]) – the psychiatric technologies would
have received 76% in the Israeli study, a weight identical
to the technologies that were in first place.
The next group includes 11 technologies, which were
ranked according to the results of the Israeli survey in
13th place. All of them were characterized identically in
the Austrian data and were ranked in the Austrian and
Spanish studies in 16th place, with the exception of two
(one in the Spanish study).
Table 5 The Israeli prioritization of the hypothetical technologies
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Table 7 Comparison of the ranking of actual technologies used in the international studyb
aThe rankings are presented for three age groups, from left to right – young, middle-age, elderly
bGreen for cardio-vascular diseases, purple for diabetes, light brown for oncological diseases, blue for respiratory diseases and grey for psychiatric disorders
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An interesting finding in Table 7 is the full corres-
pondence between the Israeli ranking and the Austrian
ranking (in the young group), of the 15 technologies at
the bottom of the table (starting from 29th place).
Discussion
In general, approximately equal weight is assigned to the
efficiency and equity considerations in the preference of
the Israeli health policy-makers participating in the survey.
This equality is prominent in the selection of the two most
important criteria – individual benefit and the concern for
the poor – whose weights were identical (19%).
Comparison of these findings with a survey of Israeli
policy-makers which was conducted in 2011 [11]1 using
general questions about the importance of various cri-
teria reveals consistency in the preferences of the policy-
makers in Israel.
While there is no difference in the weights of the
equity and efficiency considerations by age and pro-
fession (physicians vs. non-physicians) policy-makers
who have ever served on the Basket Committee ap-
pear to have a higher preference for efficiency consid-
erations than respondents who have not served on
that committee.
The comparison of the preferences of Israeli health
policy-makers with those of their colleagues in other
countries shows that Israel is unique in the balance in
the weights assigned to equity and efficiency consider-
ations. In comparison, in most other countries there is
a significant preference for efficiency considerations
over equity considerations. This gap becomes clearer if
we focus on the developed countries included in the
international study (Norway, Austria and Spain), where
the preference for efficiency over equity is stronger.
Israeli preferences agree more with the preferences
found in Brazil and Cuba.
Conclusions
In health systems around the developed world, pressure
is increasing for the creation of guidelines and instruc-
tions for policy-makers, so that their decisions will be
transparent and clear with regard to the criteria used,
and will conform to society’s values regarding efficiency
and equity. Israel is no exception to this. The process of
adoption of new technologies in Israel is well structured;
however guidelines and recommendations regarding
decision-making itself are missing. For this reason, there
is significant variation in the nature of the decisions over
the years, both regarding the positions of the individual
members of the Basket Committee in any given year,
and in the positions of different committees regarding
given technologies over time. Israeli health policy at
large suffers from similar inconsistencies and lack of
transparency.
The present study provided an assessment of the
weights assigned by Israeli policy-makers to equity and
efficiency considerations in their preferences, compared
with their peers abroad. Further research will explore how
these weights - obtained on the declarative level – match
the actual prioritization of technologies performed by the
Israeli Basket Committee.
Endnotes
1Based on the final report which was submitted to the
National Institute for Health Policy Research, as was
given to us by courtesy of the researchers and of the
National Institute.
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